In its latest Enforcement Report, the US Food and Drug Administration (USFDA) noted that the Mumbai-based drug major is recalling 24,194 pr...

PPH, if left untreated, can result in complications like anaemia in the postpartum period or aggravate mental health problems including pos...

As per the agreement, Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name Caritec...

According to industry estimates, the US generic drug market was estimated to be around $115.2 billion in 2019.

Some of the companies that announced expansions and investments include Switzerland-based Ferring Pharmaceuticals, Canadian firm Jamp Pharm...

The Global MBA program of SP Jain was recently ranked #12 in the world by Forbes.

Geneva, June 28 (IANS) A novel formulation of drug carbetocin could be safe and effective in preventing excessive bleeding following childb...

His past experiences include Business Unit Head for Reproductive Health at Ferring Pharmaceuticals, Inc and Senior Vice President of Sales ...

Glenmark's current portfolio consists of 97 products authorised for distribution in the US and 68 abbreviated new drug approvals with the U...

DIPP, the nodal body for framing FDI policy, wants to review the policy to ensure there are enough safeguards to ensure domestic healthcare...

The FIPB discussed 30 Foreign Direct Investment (FDI) proposals, including 10 from pharma sector.

The government is likely to finalise FDI policy with regard to existing drug companies ahead of the FIPB meeting on July 5.

The man credited for converting Ranbaxy into an Indian MNC, Mr Brar, today feels the Ranbaxy-Daiichi Sankyo deal is good for all the stake ...